News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Pashtoon Kasi Shared ASCO25 Results on ADG126 + Pembrolizumab in MSS Colorectal Cancer Without Liver Metastases
Pashtoon Kasi/LinkedIn
Jun 4, 2025, 23:12

Pashtoon Kasi Shared ASCO25 Results on ADG126 + Pembrolizumab in MSS Colorectal Cancer Without Liver Metastases

Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope Orange County, shared on LinkedIn:

“ASCO 2025 Continuing with the immunotherapy promise for a new subset of patients with no active liver metastases (NLM), MSS colorectal cancer – watch this:
ADG126 (Masked CTLA-4 Inhibitor) + Pembrolizumab
ORR ~29%, Sustained reduction observed.
FRUQ + Immunotherapy arm.”

Pashtoon Kasi

Title: Safety and efficacy of ADG126 (an anti-CTLA-4 masking antibody) in combination with pembrolizumab: Updated results of phase 1b/2 study in advanced MSS CRC

Journal: ASCO, JCO

Authors: Daneng Li, Sun Young Kim, Manish Patel, Hee Kyung Kim, Sunil Sharma, Sang Joon Shin, Jeeyun Lee, Sae-Won Han, Luke Chung, Songmao Zheng, Yan Li, Ping Xiao, Kristine She, Dana HuLowe, Jiangchun Xu, Stanley Frankel, Michael Chisamore, Peter Luo, Jiping Zha, Marwan Fakih

Read the full abstract.

Pashtoon Kasi

More posts featuring Pashtoon Kasi on OncoDaily.

ADG126 ASCO ASCO 2025 ASCO25 cancer City of Hope Dana HuLowe Daneng Li Hee Kyung Kim Jeeyun Lee Jiangchun Xu Jiping Zha Kristine She Luke Chung Manish Patel Marwan Fakih Michael Chisamore MSS CRC OncoDaily Oncology Pashtoon Kasi pembrolizumab Peter Luo Ping Xiao Sae-Won Han Sang Joon Shin Songmao Zheng Stanley Frankel Sun Young Kim Sunil Sharma Yan Li
Special Coverage
Insight
Jun 4, 2025, 23:12
Pashtoon Kasi Shared ASCO25 Results on ADG126 + Pembrolizumab in MSS Colorectal Cancer Without Liver Metastases
Career
Jun 4, 2025, 17:30
Fellowship and Short-Term Training Opportunities Now Open at POEM Training Centers - POEM Group
Celebrities
Jun 4, 2025, 17:16
Jessie J Diagnosed with Early-Stage Breast Cancer: What Is the Prognosis?
Blog
Jun 4, 2025, 17:13
Katy Rezvani Has Been Appointed as AACR 2026 Program Committee Co-Chair and Elected to the Association of American Physicians
Blog
Jun 4, 2025, 17:07
Teresa Amaral: The Fantastic Faculty of The ASCO and ESMO Session at ASCO25 Congress
Blog
Jun 4, 2025, 17:02
Jennifer Buell Highlights Strategic Partnership Between Agenus and Zydus
Blog
Jun 4, 2025, 16:52
Olubukola Ayodele: I Leave ASCO25 Feeling Recharged Not Just By Data But By Direction
Insight
Jun 4, 2025, 16:33
Paolo Tarantino on Sara Tolaney’s Leadership and Mentorship at ASCO 2025
Blog
Jun 4, 2025, 16:33
Maryam Lustberg: Grateful For My MASCC Family
Insight
Jun 4, 2025, 16:30
Jasmine Kamboj Celebrated ASCO Advocacy Award with Team Minnesota at ASCO 2025
Blog
Jun 4, 2025, 16:27
Hadieh Eslampanah: Happy International Cancer Survivors Day 2025 - New Life and New Beginning
Oncolibrary
Jun 4, 2025, 16:20
IMMUNOSARC II Study Results: Sunitinib Plus Nivolumab Shows Promising Activity in Advanced Extraskeletal Myxoid Chondrosarcoma (EMC)